ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2017 American Transplant Congress

    Gene Expression Signature of Subclinical Allograft Kidney ABMR Compared to Clinical ABMR.

    O. Aubert,1 C. Lefaucheur,1 S. Higgins,1 L. Hidalgo,2 J. Duong Van Huyen,1 D. Viglietti,1 X. Jouven,1 D. Glotz,1 C. Legendre,1 P. Halloran,2 A. Loupy.1

    1Paris Translational Research Center for Organ Transplantation, Paris, France; 2ATAGC, Edmonton, France

    BackgroundAntibody-mediated rejection (ABMR) is characterized by a heterogeneous presentation. It occurs in clinically stable patients (sABMR) or in patients with allograft dysfunction (ABMR), but only…
  • 2017 American Transplant Congress

    Complement Markers in Immunoadsorption Combined with Membrane Filtration.

    P. Malvezzi,1 F. Defendi,2 F. Eskandary,3 T. Jouve,1 L. Rostaing,1 C. Dumestre-Perard,2 G. Böhmig.3

    1Clinique de Néphrologie, CHUGA, Grenoble, France; 2Laboratoire d'Immunologie, CHUGA, Grenoble, France; 3Department of Medicine III, Medical University, Vienna, Austria

    Introduction: In HLA incompatible transplantation pretransplant desensitization is mandatory in order to eliminate the donor-specific alloantibody that might fix complement (C). In a randomized crossover…
  • 2017 American Transplant Congress

    The Use of Kidneys from Deceased Donors Over 80 Years in Kidney Transplantation.

    M. Pérez-Sáez,1 E. Arcos,2 J. Comas,2 J. Pascual.1

    1Nephrology, Hospital del Mar, Barcelona, Spain; 2Organització Catalana de Trasplantaments, Barcelona, Spain

    Patient survival is longer after kidney transplantation (KT) compared with remaining in the waiting list on dialysis. We have questioned if this is true also…
  • 2017 American Transplant Congress

    The Role of Urinary Chemokines in Distinguishing Causes of Renal Allograft Dysfunction.

    S. Chong,1 R. Fernando,2 M. Harber,1 C. Magee.1

    1UCL Centre for Nephrology, Royal Free Hospital, London, United Kingdom; 2Anthony Nolan Laboratories, Royal Free Hospital, London, United Kingdom

    The aetiology of renal transplant dysfunction is varied, and diagnosis often relies upon transplant biopsy, an invasive procedure that carries significant risk. Availability of a…
  • 2017 American Transplant Congress

    Transcriptomic Analysis Revealed a Fibrotic Role of Epithelial Cells Originated from the Recipient in Kidney Transplant.

    W. Zhang,1 Z. Yi,1 E. Stahl,2 M. Menon,1 K. Keung,3 K. Hao,2 P. O'Connell,3 B. Murphy.1

    1Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; 2Department of Genetics and Genomic Science, Ichan School of Medicine at Mount Sinai, New York, NY; 3Renal Unit, University of Sydney at Westmead Hospital, Sydney, Australia

    Renal fibrosis is one of major causes for chronic renal dysfunction in kidney diseases and graft loss in kidney transplant. With an aim to better…
  • 2017 American Transplant Congress

    Down but Not Out: Leucopenia Can Be Safely Treated with Reduction in Immunosuppression without Increasing Risk to the Kidney Allograft.

    A. Gilbert,1 A. Vergottini,1 A. Karabala,1 M. Grafals,1 B. Javaid,1 J. Moore,1 J. Verbesey,2 P. Abrams,2 S. Ghasemian,2 M. Cooper.2

    1Department of Medicine, Medstar Georgetown Transplant Institute, Washington, DC; 2Department of Surgery, Medstar Georgetown Transplant Institute, Washington, DC

    IntroductionLeucopenia is a growing problem with increasing immunosuppression (IS) in kidney transplantation. Reducing IS in the face of leucopenia is a concern due to the…
  • 2017 American Transplant Congress

    Outcome of Adult Living Donor Renal Transplants in Different Era: Analysis of UNOS Database.

    V. Whittaker, R. Gruessner, M. Laftavi, Z. Acun, A. Gruessner.

    Surgery, State University New York, Syracuse, NY

    Background:Living donation is the potential solution to increasing donor donor shortage. This retrospective analysis of UNOS database analyses the outcome of living donor transplantation across…
  • 2017 American Transplant Congress

    Lack of Specificity of LC-MS/MS Based Urinary Biomarkers for Polyomavirus BK Nephropathy (BKPyVN).

    G. Zeng,1 L. Pan,2 Z. Lyu,2 Y. Huang,1 P. Randhawa.1

    1Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA; 2Departments of Nephrology & Pathology, Guangxi Medical University, Nanning, Guangxi, China

    Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) based studies have suggested that BKPyVN leads to the excretion of virus-specific urinary peptides which can serve as diagnostic markers…
  • 2017 American Transplant Congress

    TGF-β1 Induces Transplant Kidney Interstitial Fibrosis Through Endothelial-to-Mesenchymal Transition via TGF-β/Smad and Akt/mTOR/p70S6K Pathways.

    Z. Wang, Z. Han, J. Tao, R. Tan, M. Gu.

    Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

    Background: Chronic allograft dysfunction (CAD) induced by kidney interstitial fibrosis is the main cause of allograft failure in kidney transplantation. Studies suggested that endothelial-to-mesenchymal transition…
  • 2017 American Transplant Congress

    Prospective Monitoring of De Novo Donor-Specific Antibodies: Incidence, Clinical Outcomes and Dynamic Changes Over 5 Years After Kidney Transplantation.

    M. Ajaimy, A. Colovai, N. Hayde, J. Graham, M. Lubetzky, L. Kamal, G. De Bocardo, E. Akalin.

    Montefiore Medical Center Transplant Center, Albert Einstein College of Medicine, Bronx

    Background: We aimed to investigate the incidence and dynamic changes of de novo donor-specific-antibodies (dnDSA) after kidney transplantation and clinical outcomes.Methods: This is a prospective…
  • « Previous Page
  • 1
  • …
  • 353
  • 354
  • 355
  • 356
  • 357
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences